On Tuesday 6th October, James Anderson (GSK), Ri De Ridder (RIZIV-INAMI), and Sophia Tickell (Meteosan) will take part in an OHE seminar to discuss the Checklist for Collaborative, Mutually Acceptable Drug Pricing.
On Tuesday 6th October, James Anderson (GSK), Ri De Ridder (RIZIV-INAMI), and Sophia Tickell (Meteosan) will take part in a panel for an OHE lunchtime seminar. The panel will present and discuss the ‘Checklist for Collaborative, Mutually Acceptable Drug Pricing’, output of the PharmaDiplomacy Dialogue.
The PharmaDiplomacy Dialogue is an EU/US leadership initiative, convened by Meteos and led by senior executives from across the health system. The ‘Checklist’ identifies concrete steps along the pharmaceutical development pathway which offer an opportunity to establish a more collaborative, systematic approach to defining value and pricing.
The aim of the seminar is to debate whether and how systematic stakeholder discussion could support a more collaborative approach to pharmaceutical pricing that benefits payers, patients, healthcare providers and companies.
View the full seminar invite here.
The seminar will be held in The York Suite, St Ermin’s Hotel, 2 Caxton Street, London SW1H 0QW. A buffet lunch will be available from 12:00 noon. The seminar will start promptly at 12.30 pm and finish promptly at 2.00 pm.
Please contact Kerry Sheppard if you wish to attend. Kerry will provide confirmation once she has received your request.
